The European Medicines Agency and the US Food Administration issued separate warnings on 13 September about ranitidine medicines, one of which is Zantac, which are widely used to treat heartburn and stomach ulcers. This follows tests that showed some products contained an impurity called N-nitrosodimethylamine (NDMA), classified as a probable carcinogen.
